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ABSTRACT
Objective: This paper aims at evaluating the benefits of vitamins and minerals found in the Speramax® supplement and the risks to mother and 
infants of additional supplementation and possible adverse interactions between micronutrients in pregnancy.
Method: A total of 30 male and 120 female albinos Swiss mice of 8–12 weeks of age weighing 25–35 g were used. Speramax was administrated 
orally for 1, 2, and 4 weeks. Fertile female mice were classified into four main groups: Group 1 is spontaneously (SPO); Group 2 is administrated with 
SperamaxÒ only; Group 3 is treated SperamaxÒ with superovulation (SUO); and Group 4 is superovulated only without Speramax.
Result: The results indicated that treatment with Speramax® showed a positive effect on neonatal development and an increase in the number of 
newborn SPO and SUO treated with Speramax® after 1 week and 2 weeks. The results showed high significance (p˂0.000) compared with SPO and 
SUO mice not treated with Speramax® and with groups treated for 4 weeks.
Conclusion: Good nutrition found in Speramax® may, therefore, be especially important to this group of infants and must be instituted alongside other 
nutritional supplements.
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INTRODUCTION
Micronutrients are minerals and vitamins important, in minute sums, for 
ordinary working, development, and improvement. Vitamins and minerals 
bolster each phase of maternal, placental, and fetal connection to empower 
a solid incubation. Females in low-pay nations frequently eat lowered 
levels of micronutrients because they are limited to specific types of food 
and have little access to natural products, vegetables, and invigorated 
foods [1]. Micronutrients are very significant to pregnancy and regularly 
given as supplements such as Vitamins E, folate, zinc, and selenium [2]. 
Poor maternal health status, alongside maternal body synthesis, digestion, 
and placental supplement supply are the primary factors that can adversely 
impact fetal improvement and have been entirely identified with unfriendly 
pregnancy result and articulation of fetal hereditary potential [3]. Folic 
corrosive is a Vitamin B that assists the body in making solid new cells. 
The human body is in need of folic corrosive, particularly those females 
who may get pregnant [4]. It is also a cancer prevention agent, critical for 
DNA combination and cell replication, and diminishes risks of ovulatory 
barrenness [5]. Speramax® is a new medicine containing a number of 
various vitamins and L-carnitine, and all involved in cell metabolism 
and used for men. The L-carnitine is involved in fatty acid oxidation; the 
vitamins act as antioxidants in the anabolism of body [6].
Vitamins and antioxidant
In the female reproductive system, high convergences of ROS in the 
female conceptive tract could likewise adversely affect the preparation 
of oocytes and cause hindrance of embryonic implantation [7,8]. They 
play a significant role in the pathogenesis of subfertility in both men and 
women [9-11]. There is now a great deal of scientific knowledge about 
the use of nutritional complements and their advantageous effects on 
both female and male fertilities [12]. Studies have shown that vitamins 
and minerals can increase your chances of success of staying pregnant.
Studies on infertile woman have shown that pre-conception folic acid 
supplementation increases folate levels and decreases homocysteine level 
in follicular fluid (FF) [13], and it enhances embryo quality and the chance 
of pregnancy [14]. In addition, folate is vital for quality and development, 
implantation, placentation, fetal development, and organ advancement [15]. 
Selenium (Se) is a component of enormous significance for human health. 
It is effectively exchanged over the placenta into embryo amid gestation; 
the overall maternal selenium content is emphatically connected with fetal 
and infant selenium state [16]. Se plays a key role in the effectiveness of the 
reproductive system and male and female fertilities. Based on this purpose, 
supplementation in the case of selenium is of maximum significance [17]. 
Studies on animals and humans show that the use of hormones more 
efficiently may help to prevent miscarriage or fetal death [18,19].
Vitamin E is a vital antioxidant for reproduction and fertility; this 
powerful antioxidant can play a critical role in oocyte maturation 
because the FF found in oocyte is rich with Vitamin E. The environment 
of FF is thought to play a role in oocyte maturation and eventual 
development of an embryo [20].
L-carnitine-interceded beta-oxidation of unsaturated fats has a well-
built-up part in vitality supply of oocytes and embryos [21] and 
the amount in the body peaks in your twenties and then decreases 
and becomes short supply as you age. It plays a role in increasing 
chances of pregnancy [22]. L-carnitine might be positive in advancing 
improvement in neonates [23,24].
METHODS
Fertile female mice were classified into four main groups: Group 1 is 
spontaneously (SPO); Group 2 is administrated with Speramax only; 
Group 3 is treated Speramax with superovulation (SUO); and Group 4 
is superovulated only without Speramax.
Ovarian stimulation (SUO induction)
SUO was performed by intraperitoneal (IP) shot of 7-point five 
international unite (I.U.) of pregnant mare’s serum gonadotropin 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i10.26780
Research Article
383
Asian J Pharm Clin Res, Vol 11, Issue 10, 2018, 382-385
 Hamzah 
(Folligon, Holland) and then followed 48 h later by IP injection of 
7-point five I.U. of human chorionic gonadotropin (Pregnyl, Serono 
company).
Mating of the animals
After isolation of the sexually mature females which at the estrous stage 
by examining the vaginal smears under a light microscope, the isolated 
females were put in breeding cages, each two females with one mature 
male and left overnight.
Early in the next morning, copulation was confirmed by examining the 
females and noticing the incidence of the vaginal plug or the sperms in 
slides microscopically in the vaginal swabs.
In this work, the gestational day 0 was characterized as the day 
when spermatozoa were seen in a spread of the vaginal substance 
or potentially a copulatory attachment and/or sperm under a light 
microscope.
Statistical analysis
All statistical analysis was achieved using version 16.0 Minitab 
statistical program. Chi-square test was also utilized. p<0.05 was 
considered statistically significant in this study [25].
RESULT
Table 1 shows the number of newborn SPO and SUO mice treated with 
Speramax® after 1, 2, and 4 weeks.
DISCUSSION
This paper evaluates the supplementation of vitamins and minerals 
found in Speramax® on pregnancy. The study shows a significant 
increase in the number of neonatal with healthy feature. It does 
not record any state of congenital anomalies in groups treated with 
Speramax® supplements for 1 and 2 weeks in pregnant animals 
compared with an untreated group. The explanation for this feature 
is that the pregnant requires folic acid during and before pregnancy. 
The World Health Organization prescribes utilization of folic corrosive 
supplementation in females among pregnancy as a piece of regular 
antenatal care [26-28]. Its increase helps in expansion of red platelet 
mass, augmentation of the uterus, and the development of the placenta 
and embryo [29]. Another research found that the folic acid is of much 
importance to the synthesis of DNA and RNA [30]. Moreover, the 
previous study explained pregnant women treated with folic acid to 
prevent the occurrence of neural tube defect [31].
The paper also shows the importance of zinc oxide supplement during 
pregnancy for healthy neonatal. Several studies of investigational 
animals and humans reveal that severe zinc lack can have deep effects 
on pregnancy outcome [32]. Zinc is an important factor required for 
fertilization and pre-implantation development [33]. All instances 
of low birth weight could be counteracted by daily utilization of a 
multivitamin containing 15–20 mg of zinc among the main trimester 
of pregnancy [34].
Selenium also plays a role in reproduction rates in humans as well as 
animals [35]. Selenium is one of the minerals whose insufficiency is 
known to prompt confusions of female reproduction [36-42]. Selenium 
insufficiency has been related with a number of unfavorable pregnancy 
results, for example, preterm conveyances and miscarriages [43]. Several 
studies reported that selenium is important for normal reproductive 
function and for the prevention of compromised pregnancies as it reduces 
the risk of miscarriage, pre-eclampsia, gestational diabetes, pregnancy-
induced hypertension, and early rupture of membranes [44,45].
Another study found that the decrease of selenium during pregnancy 
would lead to decrease of the weight of neonatal [46].
L-carnitine (L-Cn) is a fundamental compound to the cell delivering 
long 48 anchor unsaturated fatty acid to the β-oxidation pathway in 
the mitochondrial network for catabolism [47]. Various studies have 
shown a significant effect of L-carnitine supplement in embryogenesis 
and improving embryo development [48].
The importance of L-carnitine supplied to the maternal organism 
enhances intrauterine growth [49]. Carnitine can cross the placenta; 
therefore, a low carnitine level of the neonate can reflect both neonatal 
deficiency and maternal deficiency [50-52]. The significance of 
L-carnitine in enhancing oocyte quality and regenerative execution 
has been exhibited in creature and human investigations [53-58]. The 
umbilical string blood contains altogether larger amounts of free and 
aggregate L-carnitine than the relating maternal levels [59,60].
Vitamin E, the environment of the FF, is thought to play a pivotal 
role in oocyte maturation and later the eventual development of an 
embryo [61-63]. Furthermore, there are many antioxidants found in 
FF including Vitamin E, which promotes healthy oocyte maturation and 
oocyte viability; however, the results are conflicting [64-66].
Increased ROS levels have been related with poor oocyte quality, low 
fertilization rate, and impaired embryo development [67].
In a creature display, Train et al. [68] have demonstrated that oral 
organization of antioxidant (Vitamin E) decreased the negative impact 
of female maturing on the number and nature of oocytes.
CONCLUSION
This study concludes that Speramax® is not only used for male 
infertility but can also be used for female fertility potential because its 
contents are highly supplemental for oocyte maturation and embryonic 
development. Hence, good nutrition may, therefore, be especially 
important to this group of infants and must be administered alongside 
other nutritional supplements.
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